Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC BCL2 Jurkat; Acute T Cell Leukemia; Human (Homo sapiens)
Supplier: ATCC CRL2899
BCL2 Jurkat is a T lymphocyte cell line that was isolated in 2003 from the peripheral blood of a 14-year-old, male patient with leukemia, acute T cell. It was derived by transfecting the human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene. This cell line was deposited by Stanley Korsmeyer and can be used in immunology and immune system disorder research.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?